CHRONIC KIDNEY DISEASE ASSOCIATED MODERATE TO SEVERE PRURITUS

Clinical trials for CHRONIC KIDNEY DISEASE ASSOCIATED MODERATE TO SEVERE PRURITUS explained in plain language.

Never miss a new study

Get alerted when new CHRONIC KIDNEY DISEASE ASSOCIATED MODERATE TO SEVERE PRURITUS trials appear

Sign up with your email to follow new studies for CHRONIC KIDNEY DISEASE ASSOCIATED MODERATE TO SEVERE PRURITUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug shows promise for relieving debilitating itch in dialysis patients

Symptom relief Completed

This study tested a drug called nemolizumab in 258 adults with chronic kidney disease who were on dialysis and had moderate to severe itching. The goal was to see if the drug could reduce itch intensity compared to a placebo over 12 weeks. The main measure was the percentage of p…

Matched conditions: CHRONIC KIDNEY DISEASE ASSOCIATED MODERATE TO SEVERE PRURITUS

Phase: PHASE2, PHASE3 • Sponsor: Galderma R&D • Aim: Symptom relief

Last updated May 05, 2026 11:55 UTC

CHRONIC KIDNEY DISEASE ASSOCIATED MODERATE TO SEVERE PRURITUS

Get alerted when new CHRONIC KIDNEY DISEASE ASSOCIATED MODERATE TO SEVERE PRURITUS trials appear

New drug shows promise for relieving debilitating itch in dialysis patients